Literature DB >> 32134474

Clinicopathologic Analysis of Oral and Maxillofacial Solitary Fibrous Tumor.

Everton Freitas de Morais1, Hélder Domiciano Dantas Martins1, Katianne Soares Rodrigues1, Glória Maria de França1, Éricka Janine Dantas da Silveira1, Roseana de Almeida Freitas1.   

Abstract

OBJECTIVES: The aim of this systematic review was to provide an overview of the oral and maxillofacial solitary fibrous tumor (SFT) in order to determine its clinicopathologic characteristics and biological behavior.
METHODS: We conducted a systematic review in May 2019 in multiple databases. Cases diagnosed as SFT in the oral cavity and maxillofacial complex were included.
RESULTS: Seventy-three published articles were included in our systematic review, corresponding to a total of 154 cases. SFT showed a slight female predilection (53.2%), and the cheek mucosa/cheek, tongue, and palate were the most affected anatomical sites. The mean size of SFT in the oral cavity and maxillofacial region at diagnosis was 1.4 cm. Histologic features of malignancy by morphologic analysis (P < .001) were significantly associated with a larger tumor size. Surgical excision was the most frequent therapeutic modality. Recurrence and metastasis were uncommon findings in our sample.
CONCLUSIONS: Histologic features of malignancy can be important parameters of tumor behavior. Adequate surgical treatment and long-term follow-up are required for these cases. © American Society for Clinical Pathology, 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  Clinicopathologic characteristics; Neoplasms; Oral cavity; Solitary fibrous tumor

Year:  2020        PMID: 32134474     DOI: 10.1093/ajcp/aqaa027

Source DB:  PubMed          Journal:  Am J Clin Pathol        ISSN: 0002-9173            Impact factor:   2.493


  1 in total

1.  Preoperative transarterial embolization for solitary fibrous tumor of the tongue: A case report.

Authors:  On Hasegawa; Masato Watanabe; Michihide Kono; Daisuke Yunaiyama; Daichi Chikazu
Journal:  Mol Clin Oncol       Date:  2021-01-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.